Abbott (NYSE: ABT) today announced new clinical data supporting its minimally invasive therapies for treating AFib.
Positive 12-month results from the VOLT-AF IDE Study presented at the AF Symposium and simultaneously published in JACC: Clinical Electrophysiology, reinforce the Voltâ„¢ Pulsed Field Ablation (PFA) ...
Field Medical announced the presentation of clinical data from the first-in-human study of its FieldForce pulsed field ...
The medical device company presented latest clinical findings from its Field PULSE study at the atrial fibrillation symposium ...
Demonstrating Instantaneous Ablation Through High-Voltage Waveforms and Efficient Point-by-Point Pulsed Field AblationCARDIFF ...
MyHighPlains on MSN
Local mom puts heart and health first for family
WACO, Texas (FOX 44) – The month of February is known as American Heart Month, and mothers are often considered the ...
Demonstrating Instantaneous Ablation Through High-Voltage Waveforms and Efficient Point-by-Point Pulsed Field Ablation ...
Adagio Medical Holdings, Inc (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced the publication ...
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at ...
Abbott begins patient enrollment in LESS-VT study to evaluate ablation as frontline treatment for complex cardiac arrhythmia: Abbott Park, Illinois Thursday, November 22, 2018, 09 ...
Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 27 years, gives his ...
Learn about the groundbreaking approach in treating the heart with radiation, improving lives through advanced therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results